Search - tctmd.com

Displaying 501 - 520 of 2770

Sort: Relevancy | Date

News Conference News AHA 2023

AI Improves Detection of Cardiomyopathy in Pregnancy

L.A. McKeown

November 15, 2023

News Conference News AHA 2023

New CVD Risk Tool Can Spur Even Earlier Talk About Prevention

Yael L. Maxwell

November 14, 2023

News Conference News AHA 2023

Gene Editing Shuts Off PCSK9 to Lower LDL in HeFH

Caitlin E. Cox

November 12, 2023

News Conference News AHA 2023

Slash Dietary Sodium, Slash Blood Pressure: CARDIA-SSBP

Michael O'Riordan

November 12, 2023

News Opinion Editor's Corner AHA 2023

What’s Going to Be Hot at AHA 2023

Shelley Wood

November 07, 2023

News Conference News VIVA 2023

‘Dire’ Lack of Vascular Care in Underserved Areas Needs Creativity, Compassion

L.A. McKeown

November 03, 2023

News Conference News TCT 2023

Post-TAVI Conduction Abnormalities: EP Study, Registry Data Provide Snapshots

Caitlin E. Cox

November 03, 2023

News Conference News TCT 2023

MitraClip G4 Data Impress, but Some Question the Reproducibility: EXPAND G4

Yael L. Maxwell

November 02, 2023

News Daily News

AHA Throws Its Support Behind New, Independent Medical Board

Michael O'Riordan

October 30, 2023

News Conference News TCT 2023

SUMMIT: MV Replacement With Tendyne Shows Promise in Severe MR, MAC

Yael L. Maxwell

October 30, 2023

News Conference News TCT 2023

CLASP IID at 1 Year: Good Results With Both Pascal, MitraClip for Mitral TEER

Todd Neale

October 26, 2023

News Conference News TCT 2023

TRILUMINATE Deep Dive Clarifies ‘Meaningful’ QoL Gains With Tricuspid TEER

Yael L. Maxwell

October 26, 2023

Presentation TCT 2023

Interventional Procedures in High-Risk Decompensated Valvular Heart Disease

Presenter: Thomas Waggoner

October 26, 2023

Presentation TCT 2023

Patient Reported Outcomes in TTVI: Are They Meaningful?

Presenter: David Cohen

October 26, 2023

Presentation TCT 2023

Review of the Current Clinical Evidence for Transcatheter Tricuspid Valve Therapies

Presenter: Susheel Kodali

October 26, 2023

Presentation TCT 2023

Current Guideline-Directed Medical Management: Will We Ever Have Class I Management Options?

Presenter: JoAnn Lindenfeld

October 26, 2023

Presentation TCT 2023

From diagnosis to treatment: the progression of disease and why we consistently undertreat AR

Presenter: Philippe Genereux

October 26, 2023

Presentation TCT 2023

What We Now Know About Tricuspid Regurgitation Outcomes: Differences in Natural History Based on Etiology

Presenter: Rebecca Hahn

October 26, 2023

Presentation TCT 2023

TCT 720: Patient-Reported Outcomes in Tricuspid Valve Intervention: Patient Preference Results from the TRISCEND II Trial

Presenter: Colin Barker

October 26, 2023

TCT 768: Early echocardiographic and hemodynamic changes after caval aortic valve implantation for severe tricuspid regurgitation

Presentation TCT 2023

TCT 768: Early Echocardiographic and Hemodynamic Changes After Caval Valve Implantation

Presenter: Ottavia Cozzi

October 26, 2023

Advertisement

AI Improves Detection of Cardiomyopathy in Pregnancy

New CVD Risk Tool Can Spur Even Earlier Talk About Prevention

Gene Editing Shuts Off PCSK9 to Lower LDL in HeFH

Slash Dietary Sodium, Slash Blood Pressure: CARDIA-SSBP

What’s Going to Be Hot at AHA 2023

‘Dire’ Lack of Vascular Care in Underserved Areas Needs Creativity, Compassion

Post-TAVI Conduction Abnormalities: EP Study, Registry Data Provide Snapshots

MitraClip G4 Data Impress, but Some Question the Reproducibility: EXPAND G4

AHA Throws Its Support Behind New, Independent Medical Board

SUMMIT: MV Replacement With Tendyne Shows Promise in Severe MR, MAC

CLASP IID at 1 Year: Good Results With Both Pascal, MitraClip for Mitral TEER

TRILUMINATE Deep Dive Clarifies ‘Meaningful’ QoL Gains With Tricuspid TEER

Interventional Procedures in High-Risk Decompensated Valvular Heart Disease

Patient Reported Outcomes in TTVI: Are They Meaningful?

Review of the Current Clinical Evidence for Transcatheter Tricuspid Valve Therapies

Current Guideline-Directed Medical Management: Will We Ever Have Class I Management Options?

From diagnosis to treatment: the progression of disease and why we consistently undertreat AR

What We Now Know About Tricuspid Regurgitation Outcomes: Differences in Natural History Based on Etiology

TCT 720: Patient-Reported Outcomes in Tricuspid Valve Intervention: Patient Preference Results from the TRISCEND II Trial

TCT 768: Early Echocardiographic and Hemodynamic Changes After Caval Valve Implantation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content